Effects of MiR-210 on proliferation, apoptosis and invasion abilities of esophageal cancer cells. 2018

Zhiwen Cheng, and Haitao Geng, and Yufeng Cheng, and Ningxia Dong, and Fangling Ning, and Zeshun Yu, and Jinbo Jian, and Shaoshui Chen
Department of Radiotherapy, Qilu Hospital of Shandong University, Jinan 250012, P.R. China.

To investigate the effects of microRNA-210 (miRNA- 210) on the biological behaviors (proliferation and invasion) of EC109 cells of highly metastatic human esophageal cancer (EC). The EC109 genomic DNA of human EC was used as a template to amplify the precursor sequence of miRNA-210 by polymerase chain reaction (PCR). The precursor sequence of miRNA-210 was sub-cloned into the eukaryotic expression vector pcDNA3.1(-) via double digestion by BamH I and Hind III restriction enzymes. Then the pcDNA3.1 (-)-pri-miRNA-210 vector (named as p-miRNA-210) that was constructed successfully was transiently transfected into EC109 cells of human EC in vitro. Quantitative real-time PCR (qRT-PCR) was used to detect the expression level of mature miR-210. 3-(4,5-dimethyl-2-thiazolyl)-2,5- diphenyl-2-H-tetrazolium bromide (MTT) assay and scratch method were adopted to detect the proliferation and in vitro migration of EC109 cells, and flow cytometry was performed to detect the degree of cell apoptosis. The eukaryotic expression vector carrying miRNA- 210 was constructed successfully. Compared with that in the blank group (Mock) and the control group (P-Blank), miRNA-210 was overexpressed in the transfected EC109 cells. The cell apoptosis was significantly increased compared with that in the control group (p<0.05); the inhibition of proliferation of EC109 cells in the p-miRNA-210 vector transfected group was remarkably elevated (p<0.05), and wound healing ability was also significantly increased (p<0.05). The overexpression of miRNA-210 can significantly inhibit the proliferation of EC109 cells of human EC and accelerate the migration ability and the rate of apoptosis, providing a potential strategy for the treatment of EC.

UI MeSH Term Description Entries
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA

Related Publications

Zhiwen Cheng, and Haitao Geng, and Yufeng Cheng, and Ningxia Dong, and Fangling Ning, and Zeshun Yu, and Jinbo Jian, and Shaoshui Chen
July 2020, Oncology letters,
Zhiwen Cheng, and Haitao Geng, and Yufeng Cheng, and Ningxia Dong, and Fangling Ning, and Zeshun Yu, and Jinbo Jian, and Shaoshui Chen
March 2022, Panminerva medica,
Zhiwen Cheng, and Haitao Geng, and Yufeng Cheng, and Ningxia Dong, and Fangling Ning, and Zeshun Yu, and Jinbo Jian, and Shaoshui Chen
July 2020, Oncology letters,
Zhiwen Cheng, and Haitao Geng, and Yufeng Cheng, and Ningxia Dong, and Fangling Ning, and Zeshun Yu, and Jinbo Jian, and Shaoshui Chen
January 2022, Computational and mathematical methods in medicine,
Zhiwen Cheng, and Haitao Geng, and Yufeng Cheng, and Ningxia Dong, and Fangling Ning, and Zeshun Yu, and Jinbo Jian, and Shaoshui Chen
May 2019, Oncology letters,
Zhiwen Cheng, and Haitao Geng, and Yufeng Cheng, and Ningxia Dong, and Fangling Ning, and Zeshun Yu, and Jinbo Jian, and Shaoshui Chen
November 2023, European journal of medical research,
Zhiwen Cheng, and Haitao Geng, and Yufeng Cheng, and Ningxia Dong, and Fangling Ning, and Zeshun Yu, and Jinbo Jian, and Shaoshui Chen
September 2020, Experimental cell research,
Zhiwen Cheng, and Haitao Geng, and Yufeng Cheng, and Ningxia Dong, and Fangling Ning, and Zeshun Yu, and Jinbo Jian, and Shaoshui Chen
January 2023, Computational and mathematical methods in medicine,
Zhiwen Cheng, and Haitao Geng, and Yufeng Cheng, and Ningxia Dong, and Fangling Ning, and Zeshun Yu, and Jinbo Jian, and Shaoshui Chen
November 2005, Cancer biology & therapy,
Zhiwen Cheng, and Haitao Geng, and Yufeng Cheng, and Ningxia Dong, and Fangling Ning, and Zeshun Yu, and Jinbo Jian, and Shaoshui Chen
August 2019, Biochemical and biophysical research communications,
Copied contents to your clipboard!